Abstract
Background
The clinical pathway (CP) protocols simplified a systematic process from hospitalization to discharge, and were conducted to achieve standardization of the treatment process as well as improve outcomes. Thus, we investigated the optimal procedure-related hospitalization period following gastric endoscopic submucosal dissection (ESD) by comparing the rate of delayed bleeding (DB) and perforation according to CP protocols.
Methods
We retrospectively enrolled 630 patients who underwent ESD for gastric dysplasia or early gastric cancer (EGC); Group A (368 patients) followed Protocol A for a hospital stay of a single night; Group B (262 patients) followed Protocol B for a hospital stay of two nights.
Results
The patient characteristics were comparable between the two groups, except for pathologic diagnosis (42.1% in Group A vs. 32.1% in Group B for EGC). DB occurred in 21 patients, and there was no significant difference in the overall DB rates between Group A (12/368 = 3.3%) and Group B (9/262 = 3.4%) (P = 0.904). The DB rates were 2.5% (8/315) and 7.5% (4/53) in Group A, and 2.7% (6/223) and 7.7% (3/39) in Group B, without and with the use of antiplatelets, respectively, and 33.3% (1/3) in Group A and 50.0% (1/2) in Group B with the use of dual antiplatelets. DB developed at various intervals post-discharge from 2 to 17 days, and was successfully controlled by endoscopic hemostasis in most cases. There were no deaths or surgeries required as a result of uncontrolled DB and no postoperative delayed perforation occurred.
Conclusions
The CP protocols with a one-night hospitalization following gastric ESD decreased the hospital stay and did not influence postoperative complications compared to those with two-night hospitalizations.
Similar content being viewed by others
Abbreviations
- CIs:
-
Confidence intervals
- CP:
-
Clinical pathway
- DB:
-
Delayed bleeding
- EGC:
-
Early gastric cancer
- ESD:
-
Endoscopic submucosal dissection
- IT:
-
Insulation-tipped
- ORs:
-
Odds ratios
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Jung KW, Won YJ, Kong HJ, Lee ES (2019) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat 51:417–430
In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National Cancer Database. Ann Surg Oncol 24:3683–3691
Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S (2001) Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225–229
Gotoda T (2007) Endoscopic resection of early gastric cancer. Gastric Cancer 10:1–11
(2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19
Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, Amato A, Berr F, Bhandari P, Bialek A, Conio M, Haringsma J, Langner C, Meisner S, Messmann H, Morino M, Neuhaus H, Piessevaux H, Rugge M, Saunders BP, Robaszkiewicz M, Seewald S, Kashin S, Dumonceau JM, Hassan C, Deprez PH (2015) Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47:829–854
Draganov PV, Wang AY, Othman MO, Fukami N (2019) AGA institute clinical practice update: endoscopic submucosal dissection in the United States. Clin Gastroenterol Hepatol 17:16–25.e11
Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY (2009) Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 69:1228–1235
Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, Ohnita K, Mizuta Y, Shiozawa J, Kohno S (2009) Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 58:331–336
Ahn JY, Jung HY, Choi KD, Choi JY, Kim MY, Lee JH, Choi KS, Kim DH, Song HJ, Lee GH, Kim JH, Park YS (2011) Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc 74:485–493
Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, Lee JH, Kim MY, Kim BS, Oh ST, Yook JH, Jang SJ, Yun SC, Kim SO, Kim JH (2011) EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc 73:942–948
Pimentel-Nunes P, Mourao F, Veloso N, Afonso LP, Jacome M, Moreira-Dias L, Dinis-Ribeiro M (2014) Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy 46:933–940
Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Odagaki T, Taniguchi H, Kushima R, Saito Y (2013) Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy 45:703–707
Facciorusso A, Antonino M, Di Maso M, Muscatiello N (2014) Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc 6:555–563
Kim S, Cheoi KS, Lee HJ, Shim CN, Chung HS, Lee H, Shin SK, Lee SK, Lee YC, Park JC (2014) Safety and patient satisfaction of early diet after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective, randomized study. Surg Endosc 28:1321–1329
Oh KH, Lee SJ, Park JK (2017) Optimal duration of fasting period after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective evaluation. J Dig Dis 18:445–452
Choi JY, Park YS, Na G, Park SJ, Yoon H, Shin CM, Kim N, Lee DH (2019) Safety and effectiveness of endoscopic mucosal resection or endoscopic submucosal dissection for gastric neoplasia within 2 days' hospital stay. Medicine (Baltimore) 98:e16578
Oda I, Suzuki H, Nonaka S, Yoshinaga S (2013) Complications of gastric endoscopic submucosal dissection. Dig Endosc 25(Suppl 1):71–78
Kim Y, Kim YW, Choi IJ, Cho JY, Kim JH, Kwon JW, Lee JY, Lee NR, Seol SY (2015) Cost comparison between surgical treatments and endoscopic submucosal dissection in patients with early gastric cancer in Korea. Gut Liver 9:174–180
Barba R, Marco J, Canora J, Plaza S, Juncos SN, Hinojosa J, Bailon MM, Zapatero A (2015) Prolonged length of stay in hospitalized internal medicine patients. Eur J Intern Med 26:772–775
Dong J, Wei K, Deng J, Zhou X, Huang X, Deng M, Lu M (2017) Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. Gastrointest Endosc 86:807–816
Ryu HY, Kim JW, Kim HS, Park HJ, Jeon HK, Park SY, Kim BR, Lang CC, Won SH (2013) Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc 78:285–294
Kim ER, Kim JH, Kang KJ, Min BH, Lee JH, Rhee PL, Rhee JC, Kim JJ (2015) Is a second-look endoscopy necessary after endoscopic submucosal dissection for gastric neoplasm? Gut Liver 9:52–58
Ono S, Ono M, Nakagawa M, Shimizu Y, Kato M, Sakamoto N (2016) Delayed bleeding and hemorrhage of mucosal defects after gastric endoscopic submucosal dissection on second-look endoscopy. Gastric Cancer 19:561–567
Jung JH, Kim BJ, Choi CH, Kim JG (2015) Second-look endoscopy with prophylactic hemostasis is still effective after endoscopic submucosal dissection for gastric neoplasm. World J Gastroenterol 21:13518–13523
Kinsman L, Rotter T, James E, Snow P, Willis J (2010) What is a clinical pathway? Development of a definition to inform the debate. BMC Med 8:31
Chan FKL, Goh KL, Reddy N, Fujimoto K, Ho KY, Hokimoto S, Jeong YH, Kitazono T, Lee HS, Mahachai V, Tsoi KKF, Wu MS, Yan BP, Sugano K (2018) Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut 67:405–417
Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, Radaelli F, Knight E, Gralnek IM, Hassan C, Dumonceau JM (2016) Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut 65:374–389
Mochizuki S, Uedo N, Oda I, Kaneko K, Yamamoto Y, Yamashina T, Suzuki H, Kodashima S, Yano T, Yamamichi N, Goto O, Shimamoto T, Fujishiro M, Koike K (2015) Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut 64:397–405
Park CH, Park JC, Lee H, Shin SK, Lee SK, Lee YC (2015) Second-look endoscopy after gastric endoscopic submucosal dissection for reducing delayed postoperative bleeding. Gut Liver 9:43–51
Kim JS, Chung MW, Chung CY, Park HC, Ryang DY, Myung DS, Cho SB, Lee WS, Joo YE (2014) The need for second-look endoscopy to prevent delayed bleeding after endoscopic submucosal dissection for gastric neoplasms: a prospective randomized trial. Gut Liver 8:480–486
Sugimoto T, Okamoto M, Mitsuno Y, Kondo S, Ogura K, Ohmae T, Mizuno H, Yoshida S, Isomura Y, Yamaji Y, Kawabe T, Omata M, Koike K (2012) Endoscopic submucosal dissection is an effective and safe therapy for early gastric neoplasms: a multicenter feasible study. J Clin Gastroenterol 46:124–129
Toyokawa T, Inaba T, Omote S, Okamoto A, Miyasaka R, Watanabe K, Izumikawa K, Horii J, Fujita I, Ishikawa S, Morikawa T, Murakami T, Tomoda J (2012) Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 27:907–912
Koh R, Hirasawa K, Yahara S, Oka H, Sugimori K, Morimoto M, Numata K, Kokawa A, Sasaki T, Nozawa A, Taguri M, Morita S, Maeda S, Tanaka K (2013) Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc 78:476–483
So S, Ahn JY, Kim N, Na HK, Jung KW, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY (2019) Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case–control study. Gastrointest Endosc 89:277–285.e272
Acknowledgements
This work was not supported by a grant.
Author information
Authors and Affiliations
Contributions
Study design, HWK; Investigation, DK, HWK, KBK and JH; Analysis and interpretation, HWK., SMY. and HBC; Writing of manuscript, DK and HWK; Review & Editing; SMP and SJY; Supervision, HWK and HBC.
Corresponding author
Ethics declarations
Disclosures
Drs. Daehyun Kim, Hyoung Woo Kim, Ki Bae Kim, Joung-Ho Han, Soon Man Yoon, Hee Bok Chae, Seon Mee Park, and Sei Jin Youn have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kim, D., Kim, H.W., Kim, K.B. et al. Optimal procedure-related hospitalization using clinical pathway protocols following gastric endoscopic submucosal dissection. Surg Endosc 35, 2846–2854 (2021). https://doi.org/10.1007/s00464-020-07720-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07720-3